{"id":"uc-mscs-treatment","safety":{"commonSideEffects":[{"rate":"null","effect":"Bacterial infection"},{"rate":"null","effect":"Tumor progression"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"UC-MSCs treatment works by releasing anti-inflammatory cytokines and growth factors that help to reduce inflammation and promote the healing of damaged tissues. This can lead to improved outcomes in various conditions, including those related to immune system dysfunction and tissue damage.","oneSentence":"UC-MSCs treatment involves the use of umbilical cord-derived mesenchymal stem cells to modulate the immune system and promote tissue repair.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:54:39.046Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of graft-versus-host disease"}]},"trialDetails":[{"nctId":"NCT06969807","phase":"PHASE2","title":"Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease","status":"RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2025-06-09","conditions":"Diabetic Kidney Disease (DKD)","enrollment":120},{"nctId":"NCT04615429","phase":"PHASE2","title":"Double-blind, Randomized, Controlled Clinical Trial to Assess Efficacy of MSC in Patients With COVID-19 ARDS","status":"COMPLETED","sponsor":"Cristina Avendaño Solá","startDate":"2020-09-15","conditions":"Acute Respiratory Distress Syndrome, COVID-19 Pneumonia","enrollment":20},{"nctId":"NCT07452822","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Topcel-KH Pharmaceutical Co., Ltd.","startDate":"2026-02-20","conditions":"Arteriovenous Fistula Stenosis","enrollment":54},{"nctId":"NCT07431645","phase":"PHASE1","title":"Pilot Study of Radiation-Induced Xerostomia Treatment With Allogeneic Mesenchymal Stromal Stem Cells","status":"COMPLETED","sponsor":"Institute of Oncology Ljubljana","startDate":"2023-04-01","conditions":"Radiation-Induced Xerostomia, Head and Neck Cancer","enrollment":10},{"nctId":"NCT07439848","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis","status":"RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2023-12-25","conditions":"Acute Respiratory Distress Syndrome","enrollment":15},{"nctId":"NCT07441226","phase":"PHASE2","title":"Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy in Group E COPD Patients","status":"RECRUITING","sponsor":"RSUP Persahabatan","startDate":"2025-08-08","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":20},{"nctId":"NCT05008588","phase":"PHASE1, PHASE2","title":"Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct","status":"ACTIVE_NOT_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2022-05-30","conditions":"Ischemic Stroke","enrollment":15},{"nctId":"NCT05279768","phase":"PHASE1, PHASE2","title":"Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2022-09-01","conditions":"Polycystic Ovary Syndrome","enrollment":44},{"nctId":"NCT04314661","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2020-08-03","conditions":"Osteoarthritis, Knee","enrollment":31},{"nctId":"NCT04357600","phase":"PHASE1, PHASE2","title":"Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B","status":"ENROLLING_BY_INVITATION","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2018-05-17","conditions":"Liver Cirrhoses","enrollment":12},{"nctId":"NCT06040957","phase":"NA","title":"Bone Marrow Versus Adipose Tissue as a Cell Source for Infiltrative Treatment of Knee Osteoarthritis","status":"RECRUITING","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2024-01-08","conditions":"Knee Osteoarthritis","enrollment":204},{"nctId":"NCT07413549","phase":"PHASE1, PHASE2","title":"Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis","status":"RECRUITING","sponsor":"Beijing Tuohua Weiye Biotechnology Co., Ltd.","startDate":"2025-02-25","conditions":"Decompensated Hepatitis B Cirrhosis","enrollment":76},{"nctId":"NCT07413978","phase":"PHASE1, PHASE2","title":"A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress Syndrome","status":"RECRUITING","sponsor":"Changchun Tuohua Pharmaceutical Co., Ltd.","startDate":"2025-04-25","conditions":"Acute Respiratory Distress Syndrome","enrollment":36},{"nctId":"NCT04328714","phase":"PHASE1","title":"Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease","status":"TERMINATED","sponsor":"Edwin Horwitz","startDate":"2021-12-02","conditions":"Acute Leukemia, Myelodysplastic Syndromes","enrollment":4},{"nctId":"NCT05697718","phase":"PHASE1","title":"Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-S) in the Treatment of Ischemic Stroke","status":"COMPLETED","sponsor":"Shanghai IxCell Biotechnology Co., LTD","startDate":"2023-04-10","conditions":"Ischemic Stroke","enrollment":18},{"nctId":"NCT07299123","phase":"PHASE1, PHASE2","title":"Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA","status":"ENROLLING_BY_INVITATION","sponsor":"Chinese PLA General Hospital","startDate":"2023-08-01","conditions":"Severe Aplastic Anemia (SAA), Severe Aplastic Anemia, Refractory, Severe Aplastic Anemia","enrollment":40},{"nctId":"NCT07396155","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial","status":"RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2026-07-01","conditions":"Diabetic Nephropathy Type 2","enrollment":10},{"nctId":"NCT05820711","phase":"PHASE1","title":"Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2023-07-17","conditions":"Head and Neck Cancer, Xerostomia","enrollment":23},{"nctId":"NCT07295067","phase":"PHASE1","title":"Extracellular Vesicles for the Treatment of Syringomyelia","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-12-23","conditions":"Syringomyelia","enrollment":18},{"nctId":"NCT06840275","phase":"PHASE2","title":"ASCs in Recently Diagnosed Non-ischemic Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Cell to Cure ApS","startDate":"2026-03-01","conditions":"Non-Ischemic Heart Failure, Reduced Ejection Fraction Heart Failure","enrollment":90},{"nctId":"NCT05553132","phase":"PHASE1","title":"A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Daniel B. F. Saris","startDate":"2023-08-08","conditions":"Cartilage Defect","enrollment":15},{"nctId":"NCT05465096","phase":"NA","title":"Treatment of Osteoarthritis of the Hip Joint With Intra-articular Injection of Microfractured Autologous Adipose Tissue Containing Mesenchymal Stromal Cells.","status":"COMPLETED","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2022-10-24","conditions":"Hip Osteoarthritis, Hip Disease","enrollment":30},{"nctId":"NCT04356287","phase":"PHASE1, PHASE2","title":"Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis","status":"RECRUITING","sponsor":"Marie Hudson, MD","startDate":"2023-01-05","conditions":"Sclerosis, Systemic, Mesenchymal Stem Cells","enrollment":18},{"nctId":"NCT06752577","phase":"","title":"Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-12-22","conditions":"Chronic Kidney Diseases, Kidney Transplant","enrollment":75},{"nctId":"NCT06075706","phase":"PHASE2","title":"Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"medac GmbH","startDate":"2023-11-13","conditions":"Steroid-refractory Acute Graft-versus-host Disease","enrollment":48},{"nctId":"NCT04290182","phase":"PHASE1, PHASE2","title":"A Study of Local Administration of Autologous Mesenchymal Stromal Cells in Dysphonic Patients With Vocal Fold Scarring","status":"COMPLETED","sponsor":"Karolinska University Hospital","startDate":"2021-03-01","conditions":"Hoarseness, Dysphonia, Aphonia","enrollment":9},{"nctId":"NCT05331872","phase":"PHASE1","title":"Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2021-01-01","conditions":"Liver Cirrhosis","enrollment":20},{"nctId":"NCT06981741","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of hUC-MSC for the Treatment of Cartilage Damage in the Knee Joint","status":"RECRUITING","sponsor":"BIONCaRT GmbH","startDate":"2025-11-10","conditions":"Cartilage Damage","enrollment":55},{"nctId":"NCT07265349","phase":"PHASE1, PHASE2","title":"A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure","status":"RECRUITING","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2025-12-26","conditions":"Coronary Artery Bypass Grafting (CABG), Chronic Heart Failure, Chronic Ischemic Cardiomyopathy","enrollment":51},{"nctId":"NCT02962661","phase":"PHASE1","title":"Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-07-18","conditions":"Cardiomyopathy, Heart Failure, Hematopoietic and Lymphoid Cell Neoplasm","enrollment":72},{"nctId":"NCT07319533","phase":"PHASE2","title":"Clinical Trial Investigating the Effect of Exosomes as a Complementary Treatment in Severe to Moderate Erectile Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"Labbafinejad Medical Center","startDate":"2026-01","conditions":"Erectile Dysfunction, Erectile Dysfunction Associated With Type 2 Diabetes Mellitus, Erectile Dysfunction Due to Arterial Disease","enrollment":70},{"nctId":"NCT06592703","phase":"PHASE1","title":"Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis","status":"RECRUITING","sponsor":"Rennes University Hospital","startDate":"2025-03-06","conditions":"Multiple Sclerosis","enrollment":10},{"nctId":"NCT07313020","phase":"EARLY_PHASE1","title":"Handheld MPI Imaging to Track Stem Cells in Osteoarthritis","status":"ENROLLING_BY_INVITATION","sponsor":"Soochow University","startDate":"2025-12-16","conditions":"Knee Arthritis Osteoarthritis","enrollment":10},{"nctId":"NCT04452097","phase":"PHASE1, PHASE2","title":"Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS","status":"WITHDRAWN","sponsor":"Baylx Inc.","startDate":"2026-06-01","conditions":"COVID-19, ARDS, Acute Respiratory Distress Syndrome","enrollment":""},{"nctId":"NCT05595681","phase":"PHASE1","title":"Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients.","status":"TERMINATED","sponsor":"Cell to Cure ApS","startDate":"2022-12-15","conditions":"Diabetic Foot Ulcer, Mesenchymal Stromal Cells","enrollment":21},{"nctId":"NCT05705024","phase":"PHASE2","title":"Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells","status":"RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2023-09-29","conditions":"Corneal Ulcer","enrollment":38},{"nctId":"NCT05838092","phase":"PHASE3","title":"Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)","status":"ACTIVE_NOT_RECRUITING","sponsor":"RHEACELL GmbH & Co. KG","startDate":"2023-10-18","conditions":"Epidermolysis Bullosa","enrollment":9},{"nctId":"NCT05464381","phase":"PHASE3","title":"Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)","status":"ACTIVE_NOT_RECRUITING","sponsor":"RHEACELL GmbH & Co. KG","startDate":"2023-06-13","conditions":"Epidermolysis Bullosa","enrollment":91},{"nctId":"NCT06589271","phase":"PHASE1","title":"SCLife®-LDD hUC-MSCs Injection Therapy for Patients With Lumbar Intervertebral Disc Degeneration","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Lumbar Disc Degeneration","enrollment":20},{"nctId":"NCT03818854","phase":"PHASE2","title":"Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome","status":"COMPLETED","sponsor":"Michael A. Matthay","startDate":"2019-11-26","conditions":"Respiratory Distress Syndrome, Adult","enrollment":120},{"nctId":"NCT06503471","phase":"PHASE1","title":"SCLife®-UT hUC-MSCs Advanced Therapy Medicinal Products (hUC-MSCs ATMPs) for Patients With Thin Endometrial Infertility","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Infertility, Female","enrollment":24},{"nctId":"NCT03816852","phase":"PHASE2","title":"The Safety and Efficiency Study of Mesenchymal Stem Cell (19#iSCLife®-POI) in Premature Ovarian Insufficiency","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2018-10-01","conditions":"Premature Ovarian Failure","enrollment":12},{"nctId":"NCT04971161","phase":"PHASE2","title":"Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)","status":"COMPLETED","sponsor":"RHEACELL GmbH & Co. KG","startDate":"2021-08-18","conditions":"Skin Ulcer Venous Stasis Chronic","enrollment":159},{"nctId":"NCT03383081","phase":"PHASE2","title":"The Safety/Efficacy of hUC Mesenchymal Stem Cells（19#iSCLife®-OA） Therapy for Patients With Osteoarthritis","status":"RECRUITING","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2018-10-01","conditions":"Osteoarthritis, Knee","enrollment":60},{"nctId":"NCT04104412","phase":"PHASE1","title":"The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-LDP) for Lumbar Discogenic Pain","status":"RECRUITING","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2019-08-15","conditions":"Lumbar Discogenic Pain","enrollment":242},{"nctId":"NCT03608631","phase":"PHASE1, PHASE2","title":"iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-01-27","conditions":"KRAS NP_004976.2:p.G12D, Metastatic Pancreatic Adenocarcinoma, Pancreatic Ductal Adenocarcinoma","enrollment":28},{"nctId":"NCT03826433","phase":"PHASE1","title":"hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis","status":"RECRUITING","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2018-10-01","conditions":"Hepatitis B","enrollment":20},{"nctId":"NCT07232563","phase":"PHASE1","title":"Exploratory Study of Intranasal Administration of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Zhujiang Hospital","startDate":"2025-12-01","conditions":"Ischemic Stroke","enrollment":9},{"nctId":"NCT03608579","phase":"PHASE1","title":"Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-11-05","conditions":"Osteoarthritis, Hip","enrollment":24},{"nctId":"NCT04744116","phase":"EARLY_PHASE1","title":"Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-02-17","conditions":"Hematopoietic and Lymphoid Cell Neoplasm, Steroid Refractory Graft Versus Host Disease","enrollment":24},{"nctId":"NCT04456439","phase":"","title":"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)","status":"NO_LONGER_AVAILABLE","sponsor":"Mesoblast International Sàrl","startDate":"","conditions":"Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)","enrollment":""},{"nctId":"NCT05559801","phase":"PHASE1, PHASE2","title":"Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI)","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-02","conditions":"Osteogenesis Imperfecta, Osteogenesis Imperfecta Type III","enrollment":12},{"nctId":"NCT03909139","phase":"","title":"Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2019-09-06","conditions":"Acetabular Labrum Tear, Femoro Acetabular Impingement, Chondral Defect","enrollment":400},{"nctId":"NCT05456243","phase":"PHASE1","title":"Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-01-30","conditions":"Kidney Transplant","enrollment":12},{"nctId":"NCT06489028","phase":"PHASE3","title":"Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)","status":"ACTIVE_NOT_RECRUITING","sponsor":"RHEACELL GmbH & Co. KG","startDate":"2024-12-26","conditions":"Venous Leg Ulcer","enrollment":250},{"nctId":"NCT02838069","phase":"PHASE2","title":"A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2016-09-20","conditions":"Osteoarthritis","enrollment":100},{"nctId":"NCT07084012","phase":"PHASE2","title":"A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS","status":"RECRUITING","sponsor":"Shenzhen Wingor Biotechnology Co., Ltd.","startDate":"2025-08-27","conditions":"Acute Ischemic Stroke AIS","enrollment":60},{"nctId":"NCT07197606","phase":"PHASE2","title":"Clinical Trial of Umbilical Cord Mesenchymal Stem Cells in Subacute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Shanghai IxCell Biotechnology Co., LTD","startDate":"2025-10-01","conditions":"Ischemic Stroke","enrollment":86},{"nctId":"NCT07183761","phase":"PHASE2","title":"A Randomized Controlled Trial on the Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy in Subjects With Moderate to Severe Diabetic Peripheral Neuropathy","status":"NOT_YET_RECRUITING","sponsor":"Min Long","startDate":"2025-10-01","conditions":"Diabetic Peripheral Neuropathy (DPN)","enrollment":140},{"nctId":"NCT06737380","phase":"PHASE1","title":"UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients","status":"RECRUITING","sponsor":"LiveKidney.Bio","startDate":"2025-01-07","conditions":"SLE, Lupus, Systemic Lupus Erthematosus","enrollment":10},{"nctId":"NCT06464588","phase":"PHASE1","title":"A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-07-14","conditions":"Dilated Cardiomyopathy","enrollment":36},{"nctId":"NCT03211793","phase":"PHASE1, PHASE2","title":"Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2021-10-06","conditions":"Systemic Sclerosis, Digital Ulcer","enrollment":20},{"nctId":"NCT05854615","phase":"PHASE4","title":"Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease","status":"RECRUITING","sponsor":"Cell Biopeutics Resources Sdn Bhd","startDate":"2024-01-01","conditions":"Critical Limb Ischemia, Buerger's Disease","enrollment":3},{"nctId":"NCT04869397","phase":"PHASE2","title":"Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells","status":"TERMINATED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2021-06-14","conditions":"Covid19","enrollment":19},{"nctId":"NCT06954740","phase":"PHASE2","title":"Clinical Study to Evaluate the Efficacy and Safety of Mesenchymal Stromal Cells (Amimestrocel ) in Patients With Acute Kidney Injury","status":"RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2025-06-10","conditions":"Acute Kidney Injury","enrollment":50},{"nctId":"NCT07137559","phase":"","title":"CELZ-201-DDT for the Treatment of Chronic Lower Back Pain","status":"AVAILABLE","sponsor":"Creative Medical Technology Holdings Inc","startDate":"","conditions":"Chronic Back Pain, Degenerative Disc Disease Lumbar","enrollment":""},{"nctId":"NCT04629833","phase":"PHASE3","title":"Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy","status":"RECRUITING","sponsor":"medac GmbH","startDate":"2021-08-16","conditions":"Steroid-refractory Acute Graft-versus-host Disease","enrollment":210},{"nctId":"NCT04711200","phase":"PHASE1, PHASE2","title":"LYell SYndrome MEsenchymal Stromal Cells Treatment","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-04-15","conditions":"Epidermal Necrolysis, Lyell Syndrome, Toxic Epidermal Necrolysis","enrollment":15},{"nctId":"NCT04865107","phase":"PHASE2","title":"Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2021-04-27","conditions":"Covid19, Acute Respiratory Distress Syndrome","enrollment":22},{"nctId":"NCT06539273","phase":"PHASE3","title":"Exosome Treatment in Androgenetic Alopecia","status":"COMPLETED","sponsor":"Yeditepe University Hospital","startDate":"2024-01-01","conditions":"Androgenetic Alopecia, Exosomes","enrollment":30},{"nctId":"NCT04255147","phase":"PHASE1","title":"Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2022-10-17","conditions":"Bronchopulmonary Dysplasia","enrollment":9},{"nctId":"NCT07058025","phase":"PHASE2","title":"Mesenchymal Stromal Cell Therapy to Prevent Bronchopulmonary Dysplasia in Extreme Preterm Infants","status":"NOT_YET_RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2025-10-01","conditions":"Bronchopulmonary Dysplasia (BPD), ELGAN (22-28SA)","enrollment":168},{"nctId":"NCT05984628","phase":"NA","title":"Umbilical Cord Stem Cells for Skin Grafts in Donor Site Wounds","status":"RECRUITING","sponsor":"Fujian Medical University Union Hospital","startDate":"2021-10-20","conditions":"Skin Wound, Scar, Hypertrophic","enrollment":88},{"nctId":"NCT07041801","phase":"PHASE1, PHASE2","title":"Treatment of Systemic Lupus Erythematosus With Human Umbilical Cord Mesenchymal Stem Cells","status":"RECRUITING","sponsor":"Shenzhen Beike Bio-Technology Co., Ltd.","startDate":"2025-06-28","conditions":"Systemic Lupus Erythematosus (SLE)","enrollment":58},{"nctId":"NCT06886646","phase":"PHASE2","title":"Allogeneic Umbilical Cord Mesenchymal Stromal Cells for the Treatment of Chronic Antibody-Mediated Rejection in Kidney Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-09-15","conditions":"Chronic Antibody-mediated Rejection (cABMR)","enrollment":22},{"nctId":"NCT03522545","phase":"PHASE1","title":"Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2022-04-20","conditions":"Treatment-resistant Bipolar Depression","enrollment":30},{"nctId":"NCT07011199","phase":"PHASE1","title":"Clinical Outcomes of Early Kasai Surgery With Umbilical Cord MSCs in Biliary Atresia","status":"NOT_YET_RECRUITING","sponsor":"Universitas Diponegoro","startDate":"2025-06-17","conditions":"Biliary Atresia, Kasai Portoenterostomy, Mesenchymal Stem Cell Transplantation","enrollment":14},{"nctId":"NCT05724576","phase":"PHASE1","title":"Intracoronary Administration of OmniMSC-AMI for Acute ST-segment Elevation Myocardial Infarction Patients","status":"RECRUITING","sponsor":"Taiwan Bio Therapeutics Inc.","startDate":"2023-06-26","conditions":"Safety Issues","enrollment":10},{"nctId":"NCT05066334","phase":"PHASE2","title":"Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Campus Bio-Medico","startDate":"2021-03-22","conditions":"Intervertebral Disc Degeneration, Chronic Low-back Pain","enrollment":52},{"nctId":"NCT06882811","phase":"EARLY_PHASE1","title":"Human Umbilical Cord Mesenchymal Stem Cells Treatment in Sepsis","status":"RECRUITING","sponsor":"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","startDate":"2025-05-22","conditions":"Sepsis","enrollment":180},{"nctId":"NCT06981338","phase":"PHASE1, PHASE2","title":"Guttmann NeuroRecovery - Viability, Safety, and Efficacy of Intrathecal Wharton's Jelly Mesenchymal Stem Cells and Transcutaneous Spinal Cord Stimulation in Chronic Spinal Cord Injury Rehabilitation","status":"NOT_YET_RECRUITING","sponsor":"Institut Guttmann","startDate":"2025-09-01","conditions":"Spinal Cord Injuries (SCI), Spinal Cord Injury, Traumatic Spinal Cord Injuries","enrollment":10},{"nctId":"NCT05495711","phase":"PHASE1","title":"hUC Mesenchymal Stem Cells (19#iSCLife®-UT) Therapy for Patients With Thin Endometrial Infertility","status":"COMPLETED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2022-08-01","conditions":"Infertility, Female","enrollment":25},{"nctId":"NCT04896853","phase":"PHASE1","title":"Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®","status":"ACTIVE_NOT_RECRUITING","sponsor":"NextCell Pharma Ab","startDate":"2021-05-18","conditions":"COVID-19 Acute Respiratory Distress Syndrome, Influenza A, Metapneumovirus Pneumonia","enrollment":9},{"nctId":"NCT03184935","phase":"PHASE1, PHASE2","title":"Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS)","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Myelodysplastic Syndromes","enrollment":40},{"nctId":"NCT03186456","phase":"PHASE1","title":"The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Cerebral Infarction","enrollment":40},{"nctId":"NCT03180450","phase":"PHASE1, PHASE2","title":"The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF)","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Heart Failure","enrollment":60},{"nctId":"NCT05039411","phase":"PHASE1","title":"Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas w/ Crohn's Disease","status":"RECRUITING","sponsor":"CryoCord Sdn Bhd","startDate":"2022-03-01","conditions":"Perianal Fistula Due to Crohn's Disease, Fistula in Ano","enrollment":5},{"nctId":"NCT06853522","phase":"EARLY_PHASE1","title":"hucMSCs Exosomes for the Treatment of Active Ulcerative Colitis","status":"NOT_YET_RECRUITING","sponsor":"Shanghai East Hospital","startDate":"2025-05-30","conditions":"Ulcerative Colitis (UC)","enrollment":40},{"nctId":"NCT04466007","phase":"PHASE2","title":"Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia","status":"COMPLETED","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2021-01-11","conditions":"Limb Ischemia, Diabetic Foot","enrollment":90},{"nctId":"NCT04325594","phase":"PHASE1, PHASE2","title":"The Application of the Umbilical Cord Mesenchymal Stem Cells in the Complex Treatment of Non-ischemic Heart Failure","status":"COMPLETED","sponsor":"The Research-Clinical Center for Cardiac Surgery and Transplantology LLP","startDate":"2020-03-01","conditions":"Chronic Heart Failure, Non-ischemic Cardiomyopathy, Non-ischemic Dilated Cardiomyopathy","enrollment":30},{"nctId":"NCT04489732","phase":"PHASE1","title":"MSC in Patients With Xerostomia Post XRT in Head and Neck Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2022-02-18","conditions":"Xerostomia Following Radiotherapy","enrollment":6},{"nctId":"NCT06911281","phase":"PHASE1","title":"Combined Therapy of Photoelectric Instruments and Human Umbilical Cord Mesenchymal Stem Cells for Pigmentary Disorders","status":"NOT_YET_RECRUITING","sponsor":"Shanghai East Hospital","startDate":"2025-06","conditions":"Mesenchymal Stem Cells；Pigmentary Disorders","enrollment":30},{"nctId":"NCT06896344","phase":"","title":"Role of Mesenchymal Stromal Cell Derived Extracellular Vesicles of Primary Myelofibrosis Patients on CD34+ Cells","status":"RECRUITING","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2024-01-11","conditions":"Primary Myelofibrosis","enrollment":10},{"nctId":"NCT04435249","phase":"PHASE1, PHASE2","title":"ENgineered Tissue Repair of BronchopleUral FiSTula","status":"WITHDRAWN","sponsor":"Videregen Limited","startDate":"2025-10","conditions":"Bronchopleural Fistula","enrollment":""},{"nctId":"NCT06891508","phase":"NA","title":"The Placental Secretome as a Therapeutic Tool to Prevent Inflammation-induced Preterm Birth","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2025-03-11","conditions":"Preterm Birth","enrollment":60},{"nctId":"NCT03478215","phase":"PHASE2","title":"Mesenchymal Stromal Cells in Living Donor Kidney Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2016-12","conditions":"Renal Transplantation, Mesenchymal Stem Cells","enrollment":24},{"nctId":"NCT03973827","phase":"PHASE1, PHASE2","title":"Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed with Type I Diabetes","status":"COMPLETED","sponsor":"NextCell Pharma Ab","startDate":"2019-05-17","conditions":"Type1diabetes","enrollment":15},{"nctId":"NCT06862388","phase":"PHASE1, PHASE2","title":"Stem Cell Therapy for Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Tang Zhouping","startDate":"2025-03-01","conditions":"Intracerebral Hemorrhage, Mesenchymal Stem Cell","enrollment":39},{"nctId":"NCT06823063","phase":"PHASE1","title":"Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-P) in the Treatment of CTD-ILD","status":"NOT_YET_RECRUITING","sponsor":"Shanghai IxCell Biotechnology Co., LTD","startDate":"2025-04-01","conditions":"CTD-ILD","enrollment":18},{"nctId":"NCT06825169","phase":"PHASE1, PHASE2","title":"A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR101 in the Treatment of Subjects With Interstitial Lung Disease","status":"NOT_YET_RECRUITING","sponsor":"Nuwacell Biotechnologies Co., Ltd.","startDate":"2025-03-01","conditions":"Interstitial Lung Disease (ILD)","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":28,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"UC-MSCs treatment","genericName":"UC-MSCs treatment","companyName":"Shanghai East Hospital","companyId":"shanghai-east-hospital","modality":"Biologic","firstApprovalDate":"","aiSummary":"UC-MSCs treatment involves the use of umbilical cord-derived mesenchymal stem cells to modulate the immune system and promote tissue repair. Used for Treatment of graft-versus-host disease.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}